<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Cleveland JD</submitter><funding>NHLBI NIH HHS</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>National Heart Lung and Blood Institute Division of Intramural Research</funding><funding>NIH HHS</funding><pubmed_abstract>Gene-edited pig hearts may have an application for critically ill infants who are poor candidates for mechanical support. We established a pediatric animal model of gene-edited pig orthotopic cardiac xenotransplantation (OCXT) in baboons to assess its potential as a bridge to allotransplantation. Fifteen OCXTs were performed from genetically-engineered infantile pigs into size-matched baboons. Maintenance immunosuppression was founded on CD40/CD154 costimulation pathway blockade and rapamycin. After being sustained by xenografts for >4 months, 3 xenograft recipients were selected for transition to cardiac allotransplantation. Outcomes were tracked by invasive hemodynamic monitoring, surface echocardiography, and serial blood tests. After OCXT, 8 of 15 (53%) baboons achieved survival of >1 </pubmed_abstract><journal>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</journal><pagination>S1600-6135(25)03182-X</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12935157</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Gene-edited pig cardiac xenotransplantation as a bridge to allotransplantation in infants: Progress in a pig-to-baboon model.</pubmed_title><pmcid>PMC12935157</pmcid><funding_grant_id>R33 HL163718</funding_grant_id><funding_grant_id>P40 OD024628</funding_grant_id><pubmed_authors>Low S</pubmed_authors><pubmed_authors>Moreno I</pubmed_authors><pubmed_authors>Cooper DKC</pubmed_authors><pubmed_authors>Hodo CL</pubmed_authors><pubmed_authors>Katz E</pubmed_authors><pubmed_authors>Simmons J</pubmed_authors><pubmed_authors>Fenske J</pubmed_authors><pubmed_authors>Chitta S</pubmed_authors><pubmed_authors>Yeung V</pubmed_authors><pubmed_authors>Swicord W</pubmed_authors><pubmed_authors>Cleveland DC</pubmed_authors><pubmed_authors>Mitchell CB</pubmed_authors><pubmed_authors>Vo C</pubmed_authors><pubmed_authors>Weisert M</pubmed_authors><pubmed_authors>Bakshi K</pubmed_authors><pubmed_authors>Juliani J</pubmed_authors><pubmed_authors>De La Garza M</pubmed_authors><pubmed_authors>Cleveland JD</pubmed_authors><pubmed_authors>Getchell K</pubmed_authors><pubmed_authors>Neal SJ</pubmed_authors><pubmed_authors>Perrin S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gene-edited pig cardiac xenotransplantation as a bridge to allotransplantation in infants: Progress in a pig-to-baboon model.</name><description>Gene-edited pig hearts may have an application for critically ill infants who are poor candidates for mechanical support. We established a pediatric animal model of gene-edited pig orthotopic cardiac xenotransplantation (OCXT) in baboons to assess its potential as a bridge to allotransplantation. Fifteen OCXTs were performed from genetically-engineered infantile pigs into size-matched baboons. Maintenance immunosuppression was founded on CD40/CD154 costimulation pathway blockade and rapamycin. After being sustained by xenografts for >4 months, 3 xenograft recipients were selected for transition to cardiac allotransplantation. Outcomes were tracked by invasive hemodynamic monitoring, surface echocardiography, and serial blood tests. After OCXT, 8 of 15 (53%) baboons achieved survival of >1 </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-07-10T03:26:02.913Z</modification><creation>2026-07-10T03:16:20.243Z</creation></dates><accession>S-EPMC12935157</accession><cross_references><pubmed>41453738</pubmed><doi>10.1016/j.ajt.2025.12.017</doi></cross_references></HashMap>